IRADIMED CORP (IRMD) — Institutional Holders, Q2 2026 (page 3)

214 institutional investment managers reported a IRMD position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $749.3M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 214. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

IRMD 13F holders ranked 201–214 of 214

Institutional investors reporting a position in IRADIMED CORP on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
MassMutual Private Wealth & , FSB#201 · 25 sh$2.4K+108.3%
Colonial Advisors#202 · 25 sh$2.4K0.0%
SIGNATUREFD#203 · 17 sh$1.6K-19.0%
MidFirst Bank#204 · 13 sh$1.2K0.0%
WHITTIER OF NEVADA#205 · 10 sh$1.0KNew
Covestor Ltd#206 · 14 sh$1.0K+40.0%
DecisionPoint Financial#207 · 9 sh$883.000.0%
Smartleaf Asset Management#208 · 9 sh$847.000.0%
ZIONS BANCORPORATION, NATIONAL ASSOCIATION#209 · 7 sh$669.00+133.3%
True Wealth Design#210 · 5 sh$478.00-44.4%
Keating Financial Advisory Services#211 · 4 sh$382.00+33.3%
SJS Investment Consulting#212 · 2 sh$192.000.0%
ROTHSCHILD INVESTMENT#213 · 2 sh$191.00-77.8%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#214 · 9,989 sh—+26.8%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.